In elderly patients, who often have multiple conditions, polypharmacy is often appropriate but entails a risk for adverse events and, sometimes, an increased risk for morbidity […]

MONTREAL — Levels of neurofilament light chain (Nfl) may be a biomarker of chemotherapy-induced peripheral neurotoxicity (PIPN), new research suggests. Investigators found Nfl levels increased in […]

ORLANDO, Fla. — Women with heart failure with preserved ejection fraction (HFpEF) and obesity, with or without diabetes, derive the same benefit from the glucagon-like peptide […]

Orlando, Fla. — A new international consensus statement offers guidance for primary care and endocrinology providers on the care and monitoring of people who are at […]

An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2 proof-of-concept study suggest. In the trial, twice […]

Several new studies in lung cancer have opened their doors recently. Is one of your patients eligible to participate? Resected stage II, IIIA, or IIIB with […]